ArticleAnnals of medicine and surgery (2012)2026
Advances in deep brain stimulation for movement disorders.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep brain stimulation (DBS) has transformed the management of medication-refractory movement disorders, including Parkinson's disease, essential tremor, and dystonia. This letter highlights recent clinical and technological advances that enhance precision, safety, and accessibility. Innovations such as directional leads, adaptive (closed-loop) stimulation, and telemedicine-enabled remote programming enable personalized therapy and improved symptom control. Country-specific experiences illustrate these trends: China has rapidly expanded DBS centers with remote programming, European centers are adopting robotic-assisted implantation and cranialized generators, and emerging programs in Africa show promising early outcomes despite resource limitations. Multimodal imaging and intraoperative mapping have refined target accuracy, while ongoing research explores novel targets and broader indications. Our findings emphasize the importance of multidisciplinary care, evidence-based patient selection, and equitable access strategies to maximize DBS benefits. Ethical implementation and transparent reporting remain essential. By summarizing these developments, the letter underscores DBS's evolving role as a precision neuromodulation therapy improving motor function and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.